The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Natural Variation in Vif: Differential Impact on APOBEC3G/3F and a Potential Role in HIV-1 Diversification
Open accessAbstract
The HIV-1 Vif protein counteracts the antiviral activity exhibited by the host cytidine deaminases APOBEC3G and APOBEC3F. Here, we show that defective vif alleles can readily be found in HIV-1 isolates and infected patients. Single residue changes in the Vif protein sequence are sufficient to cause the loss of Vif-induced APOBEC3 neutralization. Interestingly, not all the detected defects lead to a complete inactivation of Vif function since some mutants retained selective neutralizing activity against APOBEC3F but not APOBEC3G or vice versa. Concordantly, independently hypermutated proviruses with distinguishable patterns of G-to-A substitution attributable to cytidine deamination induced by APOBEC3G, APOBEC3F, or both enzymes were present in individuals carrying proviruses with completely or partly defective Vif variants. Natural variation in Vif function may result in selective and partial neutralization of cytidine deaminases and thereby promote viral sequence diversification within HIV-1 infected individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin-Serrano, J., Zang, T., & Bieniasz, P. D. (2001) · Nature Medicine · doi:10.1038/nm1201-1313 · Cited by 710 · cited 1×
“Infection was done in the presence of 8lg/ml Polybrene, and b-galactosidase activity was quantified 48 h later using chemiluminescent substrate as previously described [50].”
MethodSelf-citationAncient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485 · cited 1×
“Host cells use DNA-editing enzymes such as APOBEC3G and APOBEC3F to inhibit the replication of exogenous and endogenous retroviruses [38,39].”
Background
Cited by
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
Simon, V., Ho, D. D., & Abdool Karim, Q. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69157-5 · Cited by 730
Self-citationHIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
Evolutionary conflicts between viruses and restriction factors shape immunity
Duggal, N. K., & Emerman, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3295 · Cited by 366
Plasma Membrane Is the Site of Productive HIV-1 Particle Assembly
Jouvenet, N., Neil, S. J. D., Bess, C., Johnson, M. C., Virgen, C. A., Simon, S. M., & Bieniasz, P. D. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040435 · Cited by 357
Self-citationDefining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Koning, F. A., Newman, E. N. C., Kim, E.-Y., Kunstman, K. J., Wolinsky, S. M., & Malim, M. H. (2009) · Journal of Virology · doi:10.1128/jvi.01089-09 · Cited by 336
Immune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses
Kirchhoff, F. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.004 · Cited by 315
Keele, B. F., Li, H., Learn, G. H., Hraber, P., Giorgi, E. E., Grayson, T., Sun, C., Chen, Y., Yeh, W. W., Letvin, N. L., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082831 · Cited by 311
Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors
Cullen, B. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1067-1076.2006 · Cited by 284
APOBEC proteins and intrinsic resistance to HIV-1 infection
Malim, M. H. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0185 · Cited by 280
T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction
Zhang, W., Du, J., Evans, S. L., Yu, Y., & Yu, X.-F. (2012) · Nature · doi:10.1038/nature10718 · Cited by 264
Intrinsic host restrictions to HIV-1 and mechanisms of viral escape
Simon, V., Bloch, N., & Landau, N. R. (2015) · Nature Immunology · doi:10.1038/ni.3156 · Cited by 260
Self-citationIdentification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family
Dang, Y., Wang, X., Esselman, W. J., & Zheng, Y.-H. (2006) · Journal of Virology · doi:10.1128/jvi.01123-06 · Cited by 255
Two-stepping through time: mammals and viruses
Meyerson, N. R., & Sawyer, S. L. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.03.006 · Cited by 133
Multifaceted antiviral actions of APOBEC3 cytidine deaminases
Chiu, Y.-L., & Greene, W. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.003 · Cited by 72
Dispersed Sites of HIV Vif-Dependent Polyubiquitination in the DNA Deaminase APOBEC3F
Albin, J. S., Anderson, J. S., Johnson, J. R., Harjes, E., Matsuo, H., Krogan, N. J., & Harris, R. S. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.01.010 · Cited by 25
Pseudodiploid genome organization AIDS full-length human immunodeficiency virus type 1 DNA synthesis
King, S. R., Duggal, N. K., Ndongmo, C. B., Pacut, C., & Telesnitsky, A. (2008) · Journal of Virology · doi:10.1128/jvi.02100-07 · Cited by 19
“Eighteen of 23 observed G-to-A mutations were in the context of GA dinucleotides, which is more consistent with APOBEC3F than 3G activity (20, 35, 39).”
Background
Metadata
- Authors
- Simon, V., Zennou, V., Murray, D., Huang, Y., Ho, D. D., & Bieniasz, P. D.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2005-07-22
- Volume
- 1
- Issue
- 1
- Pages
- e6
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2059238079
- Cited by
- 249
- References
- 2
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.